| Original language | English (US) |
|---|---|
| Pages (from-to) | 315-317 |
| Number of pages | 3 |
| Journal | Expert Review of Endocrinology and Metabolism |
| Volume | 8 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 2013 |
Bibliographical note
Funding Information:AS Kelly has received research funding from Amylin/Eli Lilly and served on a pediatric obesity advisory board (clinical trial design) for Novo Nordisk. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Keywords
- glucagon-like peptide-1 receptor agonists
- pediatric obesity
- pharmacotherapy
